Dive deeper into this product! Responsible disclosure of clinically actionable genomic findings to research participants who have chosen to receive them can advance data sharing and benefit the research participants themselves. Achieving transparency at all stages of data sharing for all relevant parties helps motivate the move towards a clear minimum global standard with regards to the return of results. The Policy on Clinically Actionable Genomic Research Results provides guidance on establishing return of results policies that can be customised to different contexts or unique settings. The guidance emphasises the need to prepare a clear, concise protocol for returning results at the start of a project, establish funding and resources to ensure accountability, develop return of results policies with local clinical standards in mind, effectively engage participants with strategies shared in the GA4GH Engagement Framework, make tools, protocols, and resources available to other study designers to promote collaboration, and engage funders to support the return of results.